Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: NATRIURETIC PEPTIDE, BRAIN - BLOOD , . Treffer: 60

2021

Valverde, I; Singh, Y; Sanchez-de-Toledo, J; Theocharis, P; Chikermane, A; Di Filippo, S; Kuciñska, B; Mannarino, S; Tamariz-Martel, A; Gutierrez-Larraya, F; Soda, G; Vandekerckhove, K; Gonzalez-Barlatay, F; McMahon, CJ; Marcora, S; Napoleone, CP; Duong, P; Tuo, G; Deri, A; Nepali, G; Ilina, M; Ciliberti, P; Miller, O; AEPC COVID-19 Rapid Response Team* Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.
Circulation. 2021; 143(1):21-32 Doi: 10.1161/CIRCULATIONAHA.120.050065
Web of Science PubMed FullText FullText_MUG

 

2020

Keppel, MH; Kolbitsch, T; Hoppe, UC; Auer, S; Felder, TK; Oberkofler, H; Mrazek, C; Haschke-Becher, E; Cadamuro, J The clinically effective use of cardiac markers by restructuring laboratory profiles at Cardiology wards.
Clin Chem Lab Med. 2020; 58(9): 1565-1571. Doi: 10.1515/cclm-2019-1229
Web of Science PubMed FullText FullText_MUG

 

2017

Lubas, A; Kade, G; Ryczek, R; Banasiak, P; Dyrla, P; Szamotulska, K; Schneditz, D; Niemczyk, S Ultrasonic evaluation of renal cortex arterial area enables differentiation between hypertensive and glomerulonephritis-related chronic kidney disease.
Int Urol Nephrol. 2017; 49(9):1627-1635 Doi: 10.1007/s11255-017-1634-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Raedle-Hurst, T; Mueller, M; Meinitzer, A; Maerz, W; Dschietzig, T Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease?
PLoS One. 2017; 12(9):e0184333-e0184333 Doi: 10.1371/journal.pone.0184333 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wakula, P; Neumann, B; Kienemund, J; Thon-Gutschi, E; Stojakovic, T; Manninger, M; Scherr, D; Scharnagl, H; Kapl, M; Pieske, B; Heinzel, FR CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.
Europace. 2017; 19(4):544-551 Doi: 10.1093/europace/euw101 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Winter, MP; Kleber, ME; Koller, L; Sulzgruber, P; Scharnagl, H; Delgado, G; Goliasch, G; März, W; Niessner, A Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction.
Thromb Haemost. 2017; 117(3):471-478 Doi: 10.1160/TH16-08-0600
Web of Science PubMed FullText FullText_MUG

 

2016

Calvier, L; Legchenko, E; Grimm, L; Sallmon, H; Hatch, A; Plouffe, BD; Schroeder, C; Bauersachs, J; Murthy, SK; Hansmann, G Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.
Heart. 2016; 102(5):390-6 Doi: 10.1136/heartjnl-2015-308365
Web of Science PubMed FullText FullText_MUG

 

Gergei, I; Krämer, BK; Scharnagl, H; Stojakovic, T; März, W; Mondorf, U Propeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study.
Biomarkers. 2016; 22(3-4):315-320 Doi: 10.1080/1354750X.2016.1252969
Web of Science PubMed FullText FullText_MUG

 

2015

Falkensammer, J; Frech, A; Duschek, N; Gasteiger, S; Stojakovic, T; Scharnagl, H; Huber, K; Fraedrich, G; Greiner, A Prognostic relevance of ischemia-modified albumin and NT-proBNP in patients with peripheral arterial occlusive disease.
Clin Chim Acta. 2015; 438(1):255-260 Doi: 10.1016/j.cca.2014.08.031
Web of Science PubMed FullText FullText_MUG

 

Galiè, N; Barberà, JA; Frost, AE; Ghofrani, HA; Hoeper, MM; McLaughlin, VV; Peacock, AJ; Simonneau, G; Vachiery, JL; Grünig, E; Oudiz, RJ; Vonk-Noordegraaf, A; White, RJ; Blair, C; Gillies, H; Miller, KL; Harris, JH; Langley, J; Rubin, LJ; AMBITION Investigators Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
N Engl J Med. 2015; 373(9):834-844 Doi: 10.1056/NEJMoa1413687
Web of Science PubMed FullText FullText_MUG

 

Kleber, ME; Koller, L; Goliasch, G; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, TB; Delgado, G; Tomaschitz, A; Pilz, S; März, W; Niessner, A Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
Circ Heart Fail. 2015; 8(1):25-32 Doi: 10.1161/CIRCHEARTFAILURE.114.001478 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koestenberger, M; Ravekes, W Mitral annular peak systolic velocity in pediatric patients with ectopic atrial tachycardia.
Eur J Pediatr. 2015; 174(8):1023-1023 Doi: 10.1007/s00431-015-2559-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koller, L; Kleber, ME; Brandenburg, VM; Goliasch, G; Richter, B; Sulzgruber, P; Scharnagl, H; Silbernagel, G; Grammer, TB; Delgado, G; Tomaschitz, A; Pilz, S; Berger, R; Mörtl, D; Hülsmann, M; Pacher, R; März, W; Niessner, A Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.
Circ Heart Fail. 2015; 8(6):1059-1067 Doi: 10.1161/CIRCHEARTFAILURE.115.002341 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Potgieter, D; Simmers, D; Ryan, L; Biccard, BM; Lurati-Buse, GA; Cardinale, DM; Chong, CP; Cnotliwy, M; Farzi, SI; Jankovic, RJ; Lim, WK; Mahla, E; Manikandan, R; Oscarsson, A; Phy, MP; Rajagopalan, S; Van Gaal, WJ; Waliszek, M; Rodseth, RN N-terminal pro-B-type Natriuretic Peptides' Prognostic Utility Is Overestimated in Meta-analyses Using Study-specific Optimal Diagnostic Thresholds.
Anesthesiology. 2015; 123(2):264-271 Doi: 10.1097/ALN.0000000000000728
Web of Science PubMed FullText FullText_MUG

 

2014

Dieplinger, B; Egger, M; Haltmayer, M; Kleber, ME; Scharnagl, H; Silbernagel, G; de Boer, RA; Maerz, W; Mueller, T Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Clin Chem. 2014; 60(3):530-540 Doi: 10.1373/clinchem.2013.209858 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Farzi, S; Mahla, E Reply from the authors.
Br J Anaesth. 2014; 112(3):587-588 Doi: 10.1093/bja/aeu042 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jhund, PS; Claggett, B; Packer, M; Zile, MR; Voors, AA; Pieske, B; Lefkowitz, M; Shi, V; Bransford, T; McMurray, JJ; Solomon, SD Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.
Eur J Heart Fail. 2014; 16(6):671-677 Doi: 10.1002/ejhf.76 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kleber, ME; Goliasch, G; Grammer, TB; Pilz, S; Tomaschitz, A; Silbernagel, G; Maurer, G; März, W; Niessner, A Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score.
J Intern Med. 2014; 276(2):184-194 Doi: 10.1111/joim.12189 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rodseth, RN; Biccard, BM; Le Manach, Y; Sessler, DI; Lurati Buse, GA; Thabane, L; Schutt, RC; Bolliger, D; Cagini, L; Cardinale, D; Chong, CP; Chu, R; Cnotliwy, M; Di Somma, S; Fahrner, R; Lim, WK; Mahla, E; Manikandan, R; Puma, F; Pyun, WB; Radović, M; Rajagopalan, S; Suttie, S; Vanniyasingam, T; van Gaal, WJ; Waliszek, M; Devereaux, PJ The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis.
J Am Coll Cardiol. 2014; 63(2):170-180 Doi: 10.1016/j.jacc.2013.08.1630 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Skrabal, F; Pichler, GP; Gratze, G; Holler, A Adding "hemodynamic and fluid leads" to the ECG. Part I: the electrical estimation of BNP, chronic heart failure (CHF) and extracellular fluid (ECF) accumulation.
MED ENG PHYS. 2014; 36(7): 896-904. Doi: 10.1016/j.medengphy.2014.03.015
Web of Science PubMed FullText FullText_MUG

 

2013

Farzi, S; Stojakovic, T; Marko, T; Sankin, C; Rehak, P; Gumpert, R; Baumann, A; Höfler, B; Metzler, H; Mahla, E Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery.
Br J Anaesth. 2013; 110(4):554-560 Doi: 10.1093/bja/aes454 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Foris, V; Kovacs, G; Tscherner, M; Olschewski, A; Olschewski, H Biomarkers in pulmonary hypertension: what do we know?
Chest. 2013; 144(1):274-283 Doi: 10.1378/chest.12-1246
Web of Science PubMed FullText FullText_MUG

 

Fritz, JS; Blair, C; Oudiz, RJ; Dufton, C; Olschewski, H; Despain, D; Gillies, H; Kawut, SM; Baseline and Follow-up 6-Min Walk Distance and Brain Natriuretic Peptide Predict 2-Year Mortality in Pulmonary Arterial Hypertension.
CHEST. 2013; 143(2): 315-323. Doi: 10.1378/chest.12-0270 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ghofrani, HA; Galiè, N; Grimminger, F; Grünig, E; Humbert, M; Jing, ZC; Keogh, AM; Langleben, D; Kilama, MO; Fritsch, A; Neuser, D; Rubin, LJ; PATENT-1 Study Group Riociguat for the treatment of pulmonary arterial hypertension.
N Engl J Med. 2013; 369(4):330-340 Doi: 10.1056/NEJMoa1209655
Web of Science PubMed FullText FullText_MUG

 

Giannitsis, E; Spanuth, E; Horsch, A; Kleber, ME; Koch, W; Grammer, TB; Koenig, W; März, W High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Clin Chem Lab Med. 2013; 51(10):2019-2028 Doi: 10.1515/cclm-2012-0786
Web of Science PubMed FullText FullText_MUG

 

Lechner, E; Weissensteiner, M; Wagner, O; Schreier-Lechner, E; Rehak, P; Prandstetter, C; Furthner, D; Wiesinger-Eidenberger, G Aminoterminal pro-B-type natriuretic peptide: heart or lung disease in the neonate?.
Pediatr Crit Care Med. 2013; 14(4):396-402 Doi: 10.1097/PCC.0b013e3182772f98
Web of Science PubMed FullText FullText_MUG

 

Luers, C; Sutcliffe, A; Binder, L; Irle, S; Pieske, B NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.
CLIN BIOCHEM. 2013; 46(12): 1013-1019. Doi: 10.1016/j.clinbiochem.2013.03.014
Web of Science PubMed FullText FullText_MUG

 

Rodseth, RN; Biccard, BM; Chu, R; Lurati Buse, GA; Thabane, L; Bakhai, A; Bolliger, D; Cagini, L; Cahill, TJ; Cardinale, D; Chong, CP; Cnotliwy, M; Di Somma, S; Fahrner, R; Lim, WK; Mahla, E; Le Manach, Y; Manikandan, R; Pyun, WB; Rajagopalan, S; Radovic, M; Schutt, RC; Sessler, DI; Suttie, S; Vanniyasingam, T; Waliszek, M; Devereaux, PJ Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis.
Anesthesiology. 2013; 119(2):270-283 Doi: 10.1097/ALN.0b013e31829083f1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Leistner, DM; Klotsche, J; Pieper, L; Stalla, GK; Lehnert, H; Silber, S; März, W; Wittchen, HU; Zeiher, AM; DETECT Study Group Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.
CLIN CHEM. 2012; 58(1): 200-208. Doi: 10.1373/clinchem.2011.174292 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ribitsch, W; Stockinger, J; Schneditz, D Bioimpedance-based volume at clinical target weight is contracted in hemodialysis patients with a high body mass index.
Clin Nephrol. 2012; 77(5):376-382 Doi: 10.5414/CN107078
Web of Science PubMed FullText FullText_MUG

 

Solomon, SD; Zile, M; Pieske, B; Voors, A; Shah, A; Kraigher-Krainer, E; Shi, V; Bransford, T; Takeuchi, M; Gong, JJ; Lefkowitz, M; Packer, M; McMurray, JJV; The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
LANCET. 2012; 380(9851): 1387-1395. Doi: 10.1016/S0140-6736(12)61227-6
Web of Science PubMed FullText FullText_MUG

 

2011

Edelmann, F; Stahrenberg, R; Polzin, F; Kockskamper, A; Dungen, HD; Duvinage, A; Binder, L; Kunde, J; Scherer, M; Gelbrich, G; Hasenfuss, G; Pieske, B; Wachter, R; Herrmann-Lingen, C Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: Quality of life in diastolic dysfunction
AMER HEART J. 2011; 161(4): 797-804. Doi: 10.1016/j.ahj.2011.01.003
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Fruhwald, FM; Ulmer, H; Pacher, R; Pölzl, G; Dornaus, C; Wieser, M; Ebner, C; Reiter, S; Kaltenbach, L; Altenberger, J; Arbeitsgruppe Herzinsuffizienz der Österreichischen Kardiologischen Gesellschaft Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry.
Wien Klin Wochenschr. 2011; 123(11-12):378-383 Doi: 10.1007/s00508-011-1591-6
Web of Science PubMed FullText FullText_MUG

 

Ivandic, BT; Spanuth, E; Kleber, M; Grammer, TB; Marz, W High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
Clin Chem Lab Med. 2011; 49(6):1053-1058 Doi: 10.1515/CCLM.2011.176
Web of Science PubMed FullText FullText_MUG

 

Mangge, H; Almer, G; Zelzer, S; Vasan, R; Kraigher-Krainer, E; Gasser, R; Schnedl, W; Ille, R; Wallner, S; Möller, R; Horejsi, R; Weghuber, D N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity.
Clin Chem Lab Med. 2011; 49(9):1539-1545 Doi: 10.1515/CCLM.2011.627
Web of Science PubMed FullText FullText_MUG

 

Rodseth, RN; Lurati Buse, GA; Bolliger, D; Burkhart, CS; Cuthbertson, BH; Gibson, SC; Mahla, E; Leibowitz, DW; Biccard, BM The predictive ability of pre-operative B-type natriuretic Peptide in vascular patients for major adverse cardiac events an individual patient data meta-analysis.
J Am Coll Cardiol. 2011; 58(5): 522-529. Doi: 10.1016/j.jacc.2011.04.018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rychli, K; Richter, B; Hohensinner, PJ; Kariem Mahdy, A; Neuhold, S; Zorn, G; Berger, R; Mörtl, D; Huber, K; Pacher, R; Wojta, J; Niessner, A; Hülsmann, M Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
Heart. 2011; 97(14):1158-1163 Doi: 10.1136/hrt.2010.220228
Web of Science PubMed FullText FullText_MUG

 

2010

Koestenbauer, S; Stiegler, P; Stadlbauer, V; Mayrhauser, U; Leber, B; Schweiger, M; Wasler, A; Prenner, G; Sereinigg, M; Zelzer, S; Stojakovic, T; Scarpatetti, M; Griesbacher, A; Greilberger, J; Tscheliessnigg, K Myeloperoxidase and carbonyl proteins: promising markers for non-invasive monitoring of graft rejection after heart transplantation.
J Heart Lung Transplant. 2010; 29(12): 1352-1357. Doi: 10.1016/j.healun.2010.05.020
Web of Science PubMed FullText FullText_MUG

 

Lüers, C; Hagenah, G; Wachter, R; Kleta, S; Schaumberg, J; Riedel, S; Binder, L; Jung, K; Schmidt, A; Pieske, B Importance of surfactant proteins B and d for the differential diagnosis of acute dyspnea.
Med Klin (Munich). 2010; 105(9):611-618 Doi: 10.1007/s00063-010-1100-0
Web of Science PubMed FullText FullText_MUG

 

Lüers, C; Schmidt, A; Wachter, R; Fritzsche, F; Sutcliffe, A; Kleta, S; Zapf, A; Hagenah, G; Binder, L; Maisch, B; Pieske, B Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure.
Herz. 2010; 35(7):488-495 Doi: 10.1007/s00059-010-3377-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

McLaughlin, VV; Benza, RL; Rubin, LJ; Channick, RN; Voswinckel, R; Tapson, VF; Robbins, IM; Olschewski, H; Rubenfire, M; Seeger, W Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
J AMER COLL CARDIOL. 2010; 55(18): 1915-1922. Doi: 10.1016/j.jacc.2010.01.027 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Badesch, DB; Champion, HC; Sanchez, MAG; Hoeper, MM; Loyd, JE; Manes, A; McGoon, M; Naeije, R; Olschewski, H; Oudiz, RJ; Torbicki, A Diagnosis and assessment of pulmonary arterial hypertension.
J AMER COLL CARDIOL. 2009; 54(1 Suppl): S55-S66. Doi: 10.1016/j.jacc.2009.04.011 [Oral Communication] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Bodlaj, G; Hubmann, R; Saleh, K; Biesenbach, G; Pohanka, E; Stojakovic, T; Berg, J Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.
Wien Klin Wochenschr. 2009; 121(19-20): 631-637. Doi: 10.1007/s00508-009-1248-x
Web of Science PubMed FullText FullText_MUG

 

Franz, MB; Andreas, M; Schiessl, B; Zeisler, H; Neubauer, A; Kastl, SP; Hess, G; Rhomberg, F; Zdunek, D; Maurer, G; Schlembach, D; Heinze, G; Szekeres, T; Gottsauner-Wolf, M NT-proBNP is increased in healthy pregnancies compared to non-pregnant controls.
Acta Obstet Gynecol Scand. 2009; 88(2):234-237 Doi: 10.1080/00016340802596025
Web of Science PubMed FullText FullText_MUG

 

2008

Cleland, J; Freemantle, N; Ghio, S; Fruhwald, F; Shankar, A; Marijanowski, M; Verboven, Y; Tavazzi, L Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
J Am Coll Cardiol. 2008; 52(6): 438-445. Doi: 10.1016/j.jacc.2008.04.036 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Galie, N; Olschewski, H; Oudiz, RJ; Torres, F; Frost, A; Ghofrani, HA; Badesch, DB; McGoon, MD; McLaughlin, VV; Roecker, EB; Gerber, MJ; Dufton, C; Wiens, BL; Rubin, LJ Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.
CIRCULATION. 2008; 117(23): 3010-3019. Doi: 10.1161/CIRCULATIONAHA.107.742510 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Herrmann-Lingen, C; Pieske, B Natriuretic peptides or psychometric tests? Prognostic markers in congestive heart failure.
Heart. 2008; 94(5):545-546 Doi: 10.1136/hrt.2007.133785
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Koch, M; Beien, A; Fusshller, A; Zitta, S; Haastert, B; Trapp, R Impact of age, body mass index, insulin resistance and proteinuria on the kidney function in obese patients with Type 2 diabetes and renal insufficiency.
Clin Nephrol. 2008; 69(1):10-17 Doi: 10.5414/CNP69010
Web of Science PubMed FullText FullText_MUG

 

Koschack, J; Scherer, M; Lurs, C; Kochen, MM; Wetzel, D; Kleta, S; Pouwels, C; Wachter, R; Herrmann-Lingen, C; Pieske, B; Binder, L Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
BMC FAM PRACT. 2008; 9: 14 Doi: 10.1186/1471-2296-9-14 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Binder, J; Ommen, SR; Chen, HH; Ackerman, MJ; Tajik, AJ; Jaffe, AS Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy.
Am J Cardiol. 2007; 100(4):712-714 Doi: 10.1016/j.amjcard.2007.03.089
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum